Filemón Bucardo1, Yaoska Reyes2, Sylvia Becker-Dreps3, Natalie Bowman3, Joann F Gruber4, Jan Vinjé5, Felix Espinoza2, Margarita Paniagua2, Angel Balmaseda6, Lennart Svensson7, Johan Nordgren7. 1. National Autonomous University of Nicaragua, León, Nicaragua. Electronic address: fili_bucardo@hotmail.com. 2. National Autonomous University of Nicaragua, León, Nicaragua. 3. School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. 4. Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, USA. 5. Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. 6. National Virology Laboratory, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua. 7. Division of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Abstract
OBJECTIVES: Investigate clinical and epidemiological factors of pediatric GII.4 norovirus infections in children with acute gastroenteritis (AGE) in Nicaragua between 1999 and 2015. METHODS: We retrospectively analyzed laboratory and epidemiologic data from 1,790 children≤7years with AGE from 6 hospitals in Nicaragua (n=538), and 3 community clinics (n=919) and households (n=333) in León, between 1999 and 2015. Moreover, asymptomatic children from community clinics (n=162) and households (n=105) were enrolled. Norovirus was detected by real-time PCR and genotyped by sequencing the N-terminal and shell region of the capsid gene. RESULTS: Norovirus was found in 19% (n=338) and 12% (n=32) of children with and without AGE, respectively. In total, 20 genotypes including a tentatively new genotype were detected. Among children with AGE, the most common genotypes were GII.4 (53%), GII.14 (7%), GII.3 (6%) and GI.3 (6%). In contrast, only one (1.4%) GII.4 was found in asymptomatic children. The prevalence of GII.4 infections was significantly higher in children between 7 and 12months of age. The prevalence of GII.4 was lowest in households (38%), followed by community clinics (50%) and hospitals (75%). Several different GII.4 variants were detected and their emergence followed the global temporal trend. CONCLUSIONS: Overall our study found the predominance of pediatric GII.4 norovirus infections in Nicaragua mostly occurring in children between 7 and 12months of age, implicating GII.4 as the main norovirus vaccine target.
OBJECTIVES: Investigate clinical and epidemiological factors of pediatric GII.4 norovirus infections in children with acute gastroenteritis (AGE) in Nicaragua between 1999 and 2015. METHODS: We retrospectively analyzed laboratory and epidemiologic data from 1,790 children≤7years with AGE from 6 hospitals in Nicaragua (n=538), and 3 community clinics (n=919) and households (n=333) in León, between 1999 and 2015. Moreover, asymptomatic children from community clinics (n=162) and households (n=105) were enrolled. Norovirus was detected by real-time PCR and genotyped by sequencing the N-terminal and shell region of the capsid gene. RESULTS:Norovirus was found in 19% (n=338) and 12% (n=32) of children with and without AGE, respectively. In total, 20 genotypes including a tentatively new genotype were detected. Among children with AGE, the most common genotypes were GII.4 (53%), GII.14 (7%), GII.3 (6%) and GI.3 (6%). In contrast, only one (1.4%) GII.4 was found in asymptomatic children. The prevalence of GII.4 infections was significantly higher in children between 7 and 12months of age. The prevalence of GII.4 was lowest in households (38%), followed by community clinics (50%) and hospitals (75%). Several different GII.4 variants were detected and their emergence followed the global temporal trend. CONCLUSIONS: Overall our study found the predominance of pediatric GII.4 norovirus infections in Nicaragua mostly occurring in children between 7 and 12months of age, implicating GII.4 as the main norovirus vaccine target.
Authors: Rebecca L Fankhauser; Stephan S Monroe; Jacqueline S Noel; Charles D Humphrey; Joseph S Bresee; Umesh D Parashar; Tamie Ando; Roger I Glass Journal: J Infect Dis Date: 2002-06-10 Impact factor: 5.226
Authors: Kari Debbink; Lisa C Lindesmith; Eric F Donaldson; Veronica Costantini; Martina Beltramello; Davide Corti; Jesica Swanstrom; Antonio Lanzavecchia; Jan Vinjé; Ralph S Baric Journal: J Infect Dis Date: 2013-08-01 Impact factor: 5.226
Authors: Annelies Kroneman; Everardo Vega; Harry Vennema; Jan Vinjé; Peter A White; Grant Hansman; Kim Green; Vito Martella; Kazuhiko Katayama; Marion Koopmans Journal: Arch Virol Date: 2013-04-25 Impact factor: 2.574
Authors: Ben Lopman; Harry Vennema; Evelyne Kohli; Pierre Pothier; Alicia Sanchez; Anabel Negredo; Javier Buesa; Eckart Schreier; Mark Reacher; David Brown; Jim Gray; Miren Iturriza; Chris Gallimore; Blenda Bottiger; Kjell-Olof Hedlund; Maria Torvén; Carl-Henrik von Bonsdorff; Leena Maunula; Mateja Poljsak-Prijatelj; Janet Zimsek; Gábor Reuter; György Szücs; Béla Melegh; Lennart Svennson; Yvonne van Duijnhoven; Marion Koopmans Journal: Lancet Date: 2004-02-28 Impact factor: 79.321
Authors: Karin Bok; Eugenio J Abente; Mauricio Realpe-Quintero; Tanaji Mitra; Stanislav V Sosnovtsev; Albert Z Kapikian; Kim Y Green Journal: J Virol Date: 2009-09-16 Impact factor: 5.103
Authors: José Victor Zambrana; Fausto Andres Bustos Carrillo; Sergio Ojeda; Brenda Lopez Mercado; Krista Latta; Amy Schiller; Guillermina Kuan; Aubree Gordon; Arthur Reingold; Eva Harris Journal: Am J Trop Med Hyg Date: 2022-06-15 Impact factor: 3.707
Authors: Sudha Bhavanam; Stephen B Freedman; Bonita E Lee; Ran Zhuo; Yuanyuan Qiu; Linda Chui; Jianling Xie; Samina Ali; Otto G Vanderkooi; Xiaoli L Pang Journal: Microorganisms Date: 2020-11-26
Authors: Yaoska Reyes; Fredman González; Lester Gutiérrez; Patricia Blandón; Edwing Centeno; Omar Zepeda; Christian Toval-Ruíz; Lisa C Lindesmith; Ralph S Baric; Nadja Vielot; Marta Diez-Valcarce; Jan Vinjé; Lennart Svensson; Sylvia Becker-Dreps; Johan Nordgren; Filemón Bucardo Journal: J Infect Dis Date: 2022-01-05 Impact factor: 7.759